ColleenSusanneDelaneyMD

Pediatric Hematology & Oncology • Seattle, WA

Assistant Professor of Pediatrics, University Wash

Join to view full profile

Dr. Delaney is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Delaney's full profile

Already have an account?

Office
825 Eastlake Ave E
Seattle, WA 98109
Phone+1 206-288-1000

Education & Training

University of WashingtonFellowship, Pediatric Hematology/Oncology, 1999 - 2002
University of California (San Francisco)Residency, Pediatrics, 1996 - 1999
Harvard Medical SchoolClass of 1996

Certifications & Licensure

CA State Medical License 1998 - Present
WA State Medical License 2001 - 2026
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic Malignancies Start of enrollment: 2006 Apr 01
Completed
Phase 1
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Start of enrollment: 2005 Nov 18
Active, not recruiting
Phase 2
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer Start of enrollment: 2008 Jun 25
Completed
Phase 2
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant Start of enrollment: 2009 Feb 24
Completed
Phase 2
Clofarabine, Cytarabine, and Filgrastim Followed by Infusion of Non-HLA Matched Ex Vivo Expanded Cord Blood Progenitors in Treating Patients With Acute Myeloid Leukemia Start of enrollment: 2009 Dec 01
Completed
Phase 1
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies Start of enrollment: 2010 Aug 01
Completed
Phase 2
Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes Start of enrollment: 2012 Dec 11
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Differentiation latency and dormancy signatures define fetal liver HSCs at single cell resolution.
Takashi Ishida, Adam M Heck, Barbara Varnum-Finney, Stacey Dozono, Cynthia Nourigat-McKay
Biorxiv. 2023-06-05
4 citations
Infectious complications after intensive chemotherapy with CLAG-M versus 7+3 for AML and other high-grade myeloid neoplasms.
Carla S Walti, Anna B Halpern, Hu Xie, Erika S Kiem, E Lisa Chung
Leukemia. 2023-02-01
8 citations
Umbilical cord blood: an undervalued and underutilized resource in allogeneic hematopoietic stem cell transplant and novel cell therapy applications.
Patricia A Shi, Larry L Luchsinger, John M Greally, Colleen S Delaney
Current Opinion in Hematology. 2022-11-01

Journal Articles

Disability Related to Chronic Graft-Versus-Host Disease After Alternative Donor Hematopoietic Cell Transplantation
Mary E Flowers, Brenda M Sandmaier, Rachel B Salit, Colleen Delaney, Filippo Milano, Stephanie J Lee, Haematologica

Abstracts/Posters

Cord Blood Transplantation Is an Effective Treatment Option in Patients with Myelodysplastic and Myeloproliferative Syndromes
Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Comparison of Outcomes between HSCT Donor Sources for Pediatric Patients with Hematologic Malignancies
Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
High Incidence of Herpes Zoster after Cord Blood Hematopoietic Cell Transplant Despite Longer Duration of Antiviral Prophylaxis
Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Demonstration of the Safety of Post Induction Infusion of Ex-Vivo Expanded Cord Blood Progenitor Cells in Pediatric Patients with Relapsed/Refractory Acute Myelogenous...
Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
No Engraftment Advantage after Single or Double Umbilical Cord Blood Transplant (CBT) with the Addition of a Non-HLA Matched Off-the-Shelf Expanded Cord Blood Unit Com...
Colleen Delaney, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Press Mentions

Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific OfficerJuly 30th, 2018
Fred Hutch Tip Sheet: Breast Cancer, Skin Cells as a Cancer Repair Mechanism, HIV Prevention Study, Air Pollution Risk and MoreAugust 24th, 2017
Kleberg Foundation Grant to Support Clinical Trial for Leukemia PatientsAugust 17th, 2017
Join now to see all